Company intelligence / Profile preview

Fizimed

Strasbourg, Grand Est, Francefizimed.com ↗

Ownership: Private
Development stage: Other

Overview

A two-year clinical study at university hospitals in Strasbourg demonstrated that the Emy Trainer led to clear improvement of symptoms in urinary incontinence for 98% of women participants. The product has thousands of users and reimbursement coverage in Germany.

Therapeutic areas: NephrologyWomen's Health
Modalities: Device (connected medical device)Mobile app (digital therapeutic adjunct)Non-pharmacological therapy (pelvic floor rehabilitation)
Industry: Therapeutic Medical Devices

Partnerships

EIT Health/EIT DigitalQuest for Health acceleratorFrench Healthcare NEXT programpartnerships with healthcare professionals and insurance providers (e.g., German statutory insurers)

Beyond the preview

Go deeper on Fizimed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fizimed.

Explore the full profile